Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

VAL

Valirx (VAL)

Valirx Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:VAL
DateTimeSourceHeadlineSymbolCompany
02/24/202511:20AMAlliance NewsAlliance NewsValiRx shares fall as ends collaboration with Imperial College LondonLSE:VALValirx Plc
02/24/20252:00AMRNS Regulatory NewsValiRx PLC Conclusion of Evaluation ProjectLSE:VALValirx Plc
02/03/20252:00AMRNS Regulatory NewsValiRx PLC Inaphaea Evaluation and Commercial Use AgreementLSE:VALValirx Plc
01/30/20252:00AMRNS Regulatory NewsValiRx PLC Extension of Evaluation AgreementLSE:VALValirx Plc
01/29/20252:00AMRNS Regulatory NewsValiRx PLC New Evaluation and Option AgreementLSE:VALValirx Plc
01/15/20257:47AMRNS Regulatory NewsValiRx PLC Holding(s) in CompanyLSE:VALValirx Plc
01/15/20256:29AMRNS Regulatory NewsValiRx PLC Holding(s) in CompanyLSE:VALValirx Plc
01/14/20252:00AMRNS Regulatory NewsValiRx PLC Holding(s) in CompanyLSE:VALValirx Plc
01/09/20256:37AMRNS Regulatory NewsValiRx PLC Holding(s) in CompanyLSE:VALValirx Plc
01/09/20256:14AMRNS Regulatory NewsValiRx PLC Holding(s) in CompanyLSE:VALValirx Plc
01/08/20252:00AMRNS Regulatory NewsValiRx PLC Holding(s) in CompanyLSE:VALValirx Plc
01/02/20256:45AMRNS Regulatory NewsValiRx PLC Holding(s) in CompanyLSE:VALValirx Plc
12/31/20248:06AMRNS Regulatory NewsValiRx PLC Holding(s) in CompanyLSE:VALValirx Plc
12/31/20245:58AMAlliance NewsAlliance NewsValiRx extends TheoremRx exclusivity period to final May 31 deadlineLSE:VALValirx Plc
12/31/20243:39AMRNS Regulatory NewsValiRx PLC Update on proposed sub-license of VAL201LSE:VALValirx Plc
12/30/20248:30AMRNS Regulatory NewsValiRx PLC Result of GM, Issue of Equity, Warrants and TVRLSE:VALValirx Plc
12/20/20242:00AMRNS Non-RegulatoryValiRx PLC ValiRx launches new interactive investor websiteLSE:VALValirx Plc
12/10/202411:45AMRNS Regulatory NewsValiRx PLC Broker Offer Results & Director/PDMR SubscriptionLSE:VALValirx Plc
12/10/202410:03AMRNS Regulatory NewsValiRx PLC Posting of Circular and Notice of General MeetingLSE:VALValirx Plc
12/09/20242:00AMRNS Regulatory NewsValiRx PLC Conditional Fundraising & Launch of Broker OfferLSE:VALValirx Plc
11/22/20242:00AMRNS Regulatory NewsValiRx PLC Inaphaea award of HEIF Funding and PhD sponsorshipLSE:VALValirx Plc
11/20/20241:09PMAlliance NewsAlliance NewsIN BRIEF: ValiRx extends Ambrose Healthcare exclusivity agreementLSE:VALValirx Plc
11/20/20242:00AMRNS Regulatory NewsValiRx PLC Update on proposed sub-license of VAL401LSE:VALValirx Plc
11/19/20246:39AMAlliance NewsAlliance NewsValiRX adds to streak of deals with cancer cell test materials winLSE:VALValirx Plc
11/19/20242:00AMRNS Regulatory NewsValiRx PLC Contract AwardLSE:VALValirx Plc
11/18/20247:21AMAlliance NewsAlliance NewsIN BRIEF: ValiRx notes subsidiary's shipment of patient derived cellsLSE:VALValirx Plc
11/18/20242:00AMRNS Regulatory NewsValiRx PLC First Sale of New Product LineLSE:VALValirx Plc
10/30/20243:00AMRNS Regulatory NewsValiRx PLC Update on proposed sub-license of VAL201LSE:VALValirx Plc
10/18/20242:00AMRNS Regulatory NewsValiRx PLC Directorate ChangeLSE:VALValirx Plc
10/14/20242:00AMRNS Regulatory NewsValiRx PLC Investor WebinarLSE:VALValirx Plc
 Showing the most relevant articles for your search:LSE:VAL